313 related articles for article (PubMed ID: 27846613)
1. Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).
Peñalver FJ; Sancho JM; de la Fuente A; Olave MT; Martín A; Panizo C; Pérez E; Salar A; Orfao A;
Haematologica; 2017 Feb; 102(2):235-245. PubMed ID: 27846613
[TBL] [Abstract][Full Text] [Related]
2. Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma.
González-Barca E; Coronado M; Martín A; Montalbán C; Montes-Moreno S; Panizo C; Rodríguez G; Sancho JM; López-Hernández A;
Oncotarget; 2018 Aug; 9(64):32383-32399. PubMed ID: 30190794
[TBL] [Abstract][Full Text] [Related]
3. Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study.
Kim SJ; Hong JS; Chang MH; Kim JA; Kwak JY; Kim JS; Yoon DH; Lee WS; Do YR; Kang HJ; Eom HS; Park Y; Won JH; Mun YC; Kim HJ; Kwon JH; Kong JH; Oh SY; Lee S; Bae SH; Yang DH; Jun HJ; Kim YS; Yun HJ; Lee SI; Kim MK; Park EK; Kim WS; Suh C
Oncotarget; 2016 Nov; 7(44):72033-72043. PubMed ID: 27713132
[TBL] [Abstract][Full Text] [Related]
4. Neuromeningeal prophylaxis for diffuse large B-cell lymphoma.
Kacem K; Zriba S
Tunis Med; 2017 Oct; 95(10):842-846. PubMed ID: 29873053
[TBL] [Abstract][Full Text] [Related]
5. Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk model.
Kansara R; Villa D; Gerrie AS; Klasa R; Shenkier T; Scott DW; Slack GW; Gascoyne RD; Connors JM; Sehn LH; Savage KJ
Br J Haematol; 2017 Nov; 179(3):508-510. PubMed ID: 27443424
[No Abstract] [Full Text] [Related]
6. [Isolated central nervous system relapse of diffuse large B-cell lymphoma in the era of immunochemotherapy].
Krmek DZ; Ljubić N; Vrbanić L
Acta Med Croatica; 2012 Dec; 66(5):403-7. PubMed ID: 23814970
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system prophylaxis in diffuse large B-cell lymphoma.
Zahid MF; Khan N; Hashmi SK; Kizilbash SH; Barta SK
Eur J Haematol; 2016 Aug; 97(2):108-20. PubMed ID: 27096423
[TBL] [Abstract][Full Text] [Related]
8. Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma.
Kim SJ; Oh SY; Kim JS; Kim H; Lee GW; Won JH; Shin HJ; Yang DH; Choi CW; Park J; Kim WS; Suh C
Ann Hematol; 2011 May; 90(5):539-46. PubMed ID: 20960190
[TBL] [Abstract][Full Text] [Related]
9. Guideline on the prevention of secondary central nervous system lymphoma: British Committee for Standards in Haematology.
McMillan A; Ardeshna KM; Cwynarski K; Lyttelton M; McKay P; Montoto S;
Br J Haematol; 2013 Oct; 163(2):168-81. PubMed ID: 24033102
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
Kridel R; Telio D; Villa D; Sehn LH; Gerrie AS; Shenkier T; Klasa R; Slack GW; Tan K; Gascoyne RD; Connors JM; Savage KJ
Br J Haematol; 2017 Jan; 176(2):210-221. PubMed ID: 27739058
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system lymphoma: A curable disease.
Batchelor TT
Hematol Oncol; 2019 Jun; 37 Suppl 1():15-18. PubMed ID: 31187523
[TBL] [Abstract][Full Text] [Related]
12. High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma.
Cheah CY; Joske D; Cull G; Gilbertson M; Opat SS; Tam CS; Wirth A; Seymour JF
Br J Haematol; 2017 Sep; 178(6):991-994. PubMed ID: 27470657
[No Abstract] [Full Text] [Related]
13. [Central nervous system involvement in diffuse large B-cell lymphoma: prevention and treatment].
Zhou D; Zhang W
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):284-5. PubMed ID: 24759011
[No Abstract] [Full Text] [Related]
14. Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma.
Qualls D; Abramson JS
Haematologica; 2019 Jan; 104(1):25-34. PubMed ID: 30573511
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic CNS directed therapy in systemic diffuse large B cell lymphoma.
Ghose A; Kundu R; Latif T
Crit Rev Oncol Hematol; 2014 Sep; 91(3):292-303. PubMed ID: 24698003
[TBL] [Abstract][Full Text] [Related]
16. Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry.
Wudhikarn K; Bunworasate U; Julamanee J; Lekhakula A; Chuncharunee S; Niparuck P; Ekwattanakit S; Khuhapinant A; Norasetthada L; Nawarawong W; Makruasi N; Kanitsap N; Sirijerachai C; Chansung K; Wong P; Numbenjapon T; Prayongratana K; Suwanban T; Wongkhantee S; Praditsuktavorn P; Intragumtornchai T;
Ann Hematol; 2017 Jan; 96(1):57-64. PubMed ID: 27752821
[TBL] [Abstract][Full Text] [Related]
17. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
Lemma SA; Pasanen AK; Haapasaari KM; Sippola A; Sormunen R; Soini Y; Jantunen E; Koivunen P; Salokorpi N; Bloigu R; Turpeenniemi-Hujanen T; Kuittinen O
Eur J Haematol; 2016 May; 96(5):492-501. PubMed ID: 26153511
[TBL] [Abstract][Full Text] [Related]
18. Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm.
Montalbán C; Díaz-López A; Martín A; Baile M; Sanchez JM; Sancho JM; García O; Novelli S; Monter-Rovira A; Salar A; Bastos M; Gutiérrez A; Bento L; Córdoba R; Arquero T; González de Villambrosia S; Barranco G; De Oña R; López Guillermo A; Rodriguez Salazar MJ; Domínguez JF; Fernández R; Queizan JA; Rodríguez J; Abraira V; García JF;
Br J Haematol; 2018 Aug; 182(4):534-541. PubMed ID: 29978453
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma.
Fox CP; Phillips EH; Smith J; Linton K; Gallop-Evans E; Hemmaway C; Auer DP; Fuller C; Davies AJ; McKay P; Cwynarski K;
Br J Haematol; 2019 Feb; 184(3):348-363. PubMed ID: 30467845
[No Abstract] [Full Text] [Related]
20. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]